AVLSA
Atlas Venture Life Science Advisors’s Akero Therapeutics AKRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-359,251
| Closed | -$8.39M | – | 17 |
|
|
2023
Q4 | $8.39M | Hold |
359,251
| – | – | 1% | 12 |
|
|
2023
Q3 | $18.2M | Sell |
359,251
-235,000
| -40% | -$11.9M | 2.81% | 11 |
|
|
2023
Q2 | $27.7M | Hold |
594,251
| – | – | 3.45% | 11 |
|
|
2023
Q1 | $22.7M | Hold |
594,251
| – | – | 3.08% | 10 |
|
|
2022
Q4 | $32.6M | Sell |
594,251
-400,000
| -40% | -$21.9M | 3.92% | 9 |
|
|
2022
Q3 | $33.9M | Sell |
994,251
-1,238,000
| -55% | -$42.2M | 3.74% | 9 |
|
|
2022
Q2 | $21.1M | Hold |
2,232,251
| – | – | 3.53% | 8 |
|
|
2022
Q1 | $31.7M | Hold |
2,232,251
| – | – | 4% | 8 |
|
|
2021
Q4 | $47.2M | Buy |
+2,232,251
| New | +$47.2M | 4.34% | 7 |
|